Fig. 2From: POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transductionHistologic grade, clinical stage, and POLE mutational status are independent prognostic factors for endometrial cancer patients. a Kaplan–Meier curve and log-rank test for endometrial cancer patients based on histologic grade classification. b Kaplan–Meier curve and log-rank test for endometrial cancer patients based on clinical stage classification. c Kaplan–Meier curve and log-rank test for endometrial cancer patients based on POLE mutational status classificationBack to article page